搜尋





搜尋





Edgewise Therapeutics Inc

EWTX

添加自選

45.320USD

-1.620-3.45%

收盤 09-18 16:00（美東）

4.89B總市值

虧損本益比TTM

盤後交易 16:13 (美東)45.220USD-0.150-0.33%

Edgewise Therapeutics Inc

45.320

-1.620-3.45%

財務摘要利潤表資產負債表現金流量表財報公司估值風險評估

概覽

新聞分析

財務

股票評分

技術分析

預測

持股情況

股息

公司資料

財務摘要利潤表資產負債表現金流量表財報公司估值風險評估

EWTX 利潤表

您可以在這裡找到Edgewise Therapeutics Inc的年度或季度收入報告，以深入了解Edgewise Therapeutics Inc的營運、管理效率和表現。

單季報

單季報+年報

單季報

年報

YOY

隱藏空白列

FY2026Q2

FY2026Q1

FY2025Q4

FY2025Q3

FY2025Q2

FY2025Q1

FY2024Q4

FY2024Q3

FY2024Q2

FY2024Q1

FY2023Q4

FY2023Q3

FY2023Q2

FY2023Q1

FY2022Q4

FY2022Q3

FY2022Q2

FY2022Q1

FY2021Q4

FY2021Q3

FY2021Q2

FY2021Q1

FY2020Q4

FY2020Q3

FY2020Q2

FY2020Q1

營業費用

45.37%61.94M

17.75%54.12M

22.92%55.98M

15.89%46.86M

11.82%42.61M

32.24%45.96M

34.49%45.54M

37.28%40.43M

50.39%38.11M

35.20%34.75M

53.37%33.86M

61.27%29.45M

53.65%25.34M

73.37%25.70M

72.20%22.08M

39.66%18.26M

57.66%16.49M

116.22%14.83M

102.11%12.82M

258.93%13.08M

164.34%10.46M

111.11%6.86M

--6.34M

--3.64M

--3.96M

--3.25M

研發費用

41.69%47.55M

16.04%42.65M

19.86%43.59M

16.32%37.48M

9.38%33.56M

32.73%36.76M

31.38%36.37M

35.47%32.22M

56.86%30.68M

39.33%27.69M

66.65%27.68M

71.20%23.79M

57.71%19.56M

78.68%19.88M

82.79%16.61M

40.63%13.89M

57.77%12.40M

107.54%11.12M

76.84%9.09M

205.13%9.88M

116.02%7.86M

80.65%5.36M

--5.14M

--3.24M

--3.64M

--2.97M

折舊攤銷及損耗

3.44%541.00K

-3.07%537.00K

-16.53%525.00K

-2.97%523.00K

8.96%523.00K

17.12%554.00K

30.23%629.00K

20.04%539.00K

13.21%480.00K

142.56%473.00K

448.86%483.00K

349.00%449.00K

337.11%424.00K

134.94%195.00K

12.82%88.00K

56.25%100.00K

90.20%97.00K

5.06%83.00K

56.00%78.00K

28.00%64.00K

13.33%51.00K

97.50%79.00K

--50.00K

--45.00K

--40.00K

營業利潤

-45.37%-61.94M

-17.75%-54.12M

-22.92%-55.98M

-15.89%-46.86M

-11.82%-42.61M

-32.24%-45.96M

-34.49%-45.54M

-37.28%-40.43M

-50.39%-38.11M

-35.20%-34.75M

-53.37%-33.86M

-61.27%-29.45M

-53.65%-25.34M

-73.37%-25.70M

-72.20%-22.08M

-39.66%-18.26M

-57.66%-16.49M

-116.22%-14.83M

-102.11%-12.82M

-258.93%-13.08M

-164.34%-10.46M

-111.11%-6.86M

---6.34M

---3.64M

---3.96M

---3.25M

淨非營業利息收入（費用）

利息收入

-28.93%4.62M

-1.14%5.10M

-1.96%5.76M

-1.76%6.19M

-1.74%6.50M

-17.13%5.16M

58.05%5.88M

68.57%6.30M

70.80%6.61M

117.31%6.23M

39.60%3.72M

389.40%3.74M

812.74%3.87M

1626.51%2.87M

2014.29%2.66M

501.57%764.00K

296.26%424.00K

295.24%166.00K

6200.00%126.00K

12600.00%127.00K

3466.67%107.00K

-33.33%42.00K

--2.00K

--1.00K

--3.00K

--63.00K

稅前利潤

-58.73%-57.33M

-20.14%-49.01M

-26.61%-50.22M

-19.15%-40.67M

-14.66%-36.12M

-43.03%-40.80M

-31.58%-39.66M

-32.73%-34.13M

-46.71%-31.50M

-24.90%-28.52M

-55.26%-30.14M

-46.95%-25.71M

-33.62%-21.47M

-55.78%-22.84M

-52.92%-19.41M

-35.13%-17.50M

-55.19%-16.07M

-115.11%-14.66M

-100.19%-12.70M

-255.55%-12.95M

-161.84%-10.35M

-113.97%-6.81M

---6.34M

---3.64M

---3.95M

---3.19M

所得稅

----

--0.00

----

除稅後利潤

-58.73%-57.33M

-20.14%-49.01M

-26.61%-50.22M

-19.15%-40.67M

-14.66%-36.12M

-43.03%-40.80M

-31.58%-39.66M

-32.73%-34.13M

-46.71%-31.50M

-24.90%-28.52M

-55.26%-30.14M

-46.95%-25.71M

-33.62%-21.47M

-55.78%-22.84M

-52.92%-19.41M

-35.13%-17.50M

-55.19%-16.07M

-115.11%-14.66M

-100.19%-12.70M

-255.55%-12.95M

-161.84%-10.35M

-113.97%-6.81M

---6.34M

---3.64M

---3.95M

---3.19M

持續經營利潤

-58.73%-57.33M

-20.14%-49.01M

-26.61%-50.22M

-19.15%-40.67M

-14.66%-36.12M

-43.03%-40.80M

-31.58%-39.66M

-32.73%-34.13M

-46.71%-31.50M

-24.90%-28.52M

-55.26%-30.14M

-46.95%-25.71M

-33.62%-21.47M

-55.78%-22.84M

-52.92%-19.41M

-35.13%-17.50M

-55.19%-16.07M

-115.11%-14.66M

-100.19%-12.70M

-255.55%-12.95M

-161.84%-10.35M

-113.97%-6.81M

---6.34M

---3.64M

---3.95M

---3.19M

歸属于母公司的淨利潤

-58.73%-57.33M

-20.14%-49.01M

-26.61%-50.22M

-19.15%-40.67M

-14.66%-36.12M

-43.03%-40.80M

-31.58%-39.66M

-32.73%-34.13M

-46.71%-31.50M

-24.90%-28.52M

-55.26%-30.14M

-46.95%-25.71M

-33.62%-21.47M

-55.78%-22.84M

-52.92%-19.41M

-35.13%-17.50M

-55.19%-16.07M

-115.11%-14.66M

-100.19%-12.70M

-255.55%-12.95M

-161.84%-10.35M

-113.97%-6.81M

---6.34M

---3.64M

---3.95M

---3.19M

歸屬普通股東的淨利潤

-58.73%-57.33M

-20.14%-49.01M

-26.61%-50.22M

-19.15%-40.67M

-14.66%-36.12M

-43.03%-40.80M

-31.58%-39.66M

-32.73%-34.13M

-46.71%-31.50M

-24.90%-28.52M

-55.26%-30.14M

-46.95%-25.71M

-33.62%-21.47M

-55.78%-22.84M

-52.92%-19.41M

-35.13%-17.50M

-55.19%-16.07M

-115.11%-14.66M

-100.19%-12.70M

-255.55%-12.95M

-161.84%-10.35M

-113.97%-6.81M

---6.34M

---3.64M

---3.95M

---3.19M

基本每股收益

-54.71%-0.53

-6.69%-0.46

-13.11%-0.47

-5.96%-0.39

-2.18%-0.34

-31.66%-0.43

10.02%-0.42

10.21%-0.36

0.57%-0.34

9.76%-0.33

-51.79%-0.47

-20.05%-0.41

-4.62%-0.34

-21.99%-0.36

-19.50%-0.31

-28.41%-0.34

-54.05%-0.32

-106.53%-0.30

-92.38%-0.26

-243.27%-0.26

-152.86%-0.21

-113.96%-0.14

---0.13

---0.08

---0.07

稀釋每股收益

-54.71%-0.53

-6.69%-0.46

-13.11%-0.47

-5.96%-0.39

-2.18%-0.34

-31.66%-0.43

10.02%-0.42

10.21%-0.36

0.57%-0.34

9.76%-0.33

-51.79%-0.47

-20.05%-0.41

-4.62%-0.34

-21.99%-0.36

-19.50%-0.31

-28.41%-0.34

-54.05%-0.32

-106.53%-0.30

-92.38%-0.26

-243.27%-0.26

-152.86%-0.21

-113.96%-0.14

---0.13

---0.08

---0.07

每股派息

--0.00

貨幣單位

--USD

審計意見

----

常見問題

如何在 TradingKey 上查看 Edgewise Therapeutics Inc 的利潤表？



先看總營收，再依序查看營業成本、毛利、營業費用、營業利益、稅前淨利、淨利和每股盈餘（EPS）。營收反映公司的業務規模，而各項獲利和利潤率則體現公司能否有效地將營收轉化為獲利。

季度利潤表和年度利潤表有什麼區別？



季度利潤表反映公司在一個為期三個月的財務季度內的經營表現，年度損益表則彙總整個財年的業績。季度數據適合用於觀察近期發展勢頭和季節性變化，年度數據則更適合評估長期成長、獲利能力和業務週期。

利潤表頁面中的同比是什麼意思？



同比（即年增率，YoY）是指將某項財務指標與上年同期進行比較，例如將本季度營收與去年同一季度的營收進行對比。與去年同期比較的數據有助於投資者觀察成長趨勢，同時減少正常季節性變化對分析的影響。

分析 EWTX 股票時，哪些利潤表指標最重要？



重要的指標包括營收成長、毛利、毛利率、營業利益、營業利益率、淨利、每股盈餘、研發費用、銷售及管理費用以及所得稅費用。投資者通常會綜合分析這些指標，以判斷公司是否正在成長、有效控制成本並提升獲利能力。

Edgewise Therapeutics Inc 全年的淨利潤是多少？



Edgewise Therapeutics Inc 2025 財年淨利潤為 -167.79M。

Edgewise Therapeutics Inc 上一季度的淨利潤是多少？



Edgewise Therapeutics Inc 最近一個季度的淨利潤為 -57.33M。

Edgewise Therapeutics Inc 年度營業利潤是多少？



Edgewise Therapeutics Inc 2025 財年的營業利潤為 -191.41M。

每股收益與利潤表有什麼關係？



每股收益（EPS）通常以淨利潤除以流通在外的股份數量計算，用於衡量公司平均每股創造的利潤。分析 EPS 時，還應結合股本變化、利潤率、現金流和估值指標進行綜合判斷。